BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28857013)

  • 1. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
    Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
    Song CG; Wu XY; Wang C; Fu FM; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
    Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
    Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
    Wang S; Li H; Wang J; Wang D; Yao A; Li Q
    Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-125a-5p expression is associated with the age of breast cancer patients.
    He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
    Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
    Liu W; Xu Y; Guan H; Meng H
    Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.
    Minemura H; Takagi K; Miki Y; Shibahara Y; Nakagawa S; Ebata A; Watanabe M; Ishida T; Sasano H; Suzuki T
    Cancer Sci; 2015 Nov; 106(11):1642-50. PubMed ID: 26331797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
    Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
    Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.